restasis multidose

What is Restasis Multidose?

From the FDA label:Cyclosporine ophthalmic emulsion, 0.05% contains a topical calcineurin inhibitor immunosuppressant with anti-inflammatory effects. Cyclosporine’s chemical name is Cyclo[[( E )-(2 S ,3 R ,4 R )-3-hydroxy-4-methyl-2-(methylamino)-6-octenoyl]-L-2-aminobutyryl- N -methylglycyl- N -methyl-L-leucyl-L-valyl- N -methyl-L-leucyl-L-alanyl-D-alanyl- N -methyl-L-leucyl- N -methyl-L-leucyl- N -methyl-L-valyl] and it has the following structure: Structural Formula Formula: C 62 H 111 N 11 O 12 Mol. Wt.: 1202.6 Cyclosporine is a fine white powder. Cyclosporine ophthalmic emulsion appears as a white opaque to slightly translucent homogeneous emulsion. It has an osmolality of 230 to 320 mOsmol/kg and a pH of 6.5-8.0. Each mL of cyclosporine ophthalmic emulsion contains: Active: cyclosporine 0.05%. Inactives: glycerin; castor oil; polysorbate 80; carbomer copolymer type A; purified water; and sodium hydroxide to adjust pH. Structural Formula

How to use

Side effects

Warnings

Who should not take Restasis Multidose

Foods & drinks to be careful with

Well-established interactions for this medicine’s drug class, summarized from public health authorities. General information, not medical advice — always confirm with your pharmacist or the label.

• Grapefruit & grapefruit juice

  Watch out for: grapefruit and grapefruit juice (and, for some drugs, Seville oranges).

  Grapefruit blocks a gut enzyme (CYP3A4) that normally breaks this medicine down, so more of it can enter your blood — raising the risk of side effects.

  What to do: Avoid grapefruit and grapefruit juice with this medicine unless your pharmacist or the label says it's fine — check, because not every drug in a class is affected the same way.

  Source: Grapefruit Juice and Some Drugs Don't Mix — U.S. FDA

How long does Cyclosporine stay in your body?

The elimination half-life of cyclosporine is about 8.4 hours (range 5 to 18 hours) — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This figure is for the modified formulation (Neoral). Cyclosporine's disposition from blood is biphasic; the ~8.4-hour value is the terminal (elimination) half-life, not the faster distribution phase. The older non-modified formulation (Sandimmune) has a longer terminal half-life of about 19 hours (range 10 to 27 hours), so the number depends on which product a person takes. Half-life is not the same as the drug-test/detection window — elimination is almost entirely biliary (only ~6% appears in urine), and cyclosporine is extensively metabolized to numerous metabolites, so measurable drug can persist longer than the parent half-life implies. Not a prodrug; no single active metabolite that clinically outlasts the parent.

This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: NEORAL (cyclosporine) capsule/oral solution — FDA label, DailyMed.

Frequently asked questions

What does Restasis Multidose treat?

Restasis Multidose (Cyclosporine) may be used to treat rheumatoid arthritis, focal segmental glomerulosclerosis, systemic lupus erythematosus, myasthenia gravis, psoriasis, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.

How does Restasis Multidose work?

Restasis Multidose is a calcineurin inhibitor immunosuppressant. Calcineurin inhibitors block an enzyme called calcineurin inside immune T-cells, which stops the cells from making interleukin-2 and other signaling chemicals. This keeps T-cells from activating and multiplying, dialing down the immune attack that drives organ rejection or autoimmune disease.

How is Restasis Multidose rated?

pharmaranks gives Restasis Multidose a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

How much does Restasis Multidose cost?

Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $52.85 for 30, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.

Is there a coupon or discount for Restasis Multidose?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Restasis Multidose. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Restasis Multidose?

Restasis Multidose is marketed by Abbvie. You can see Abbvie's full profile, rating, and other products on pharmaranks.

Is Restasis Multidose a brand-name or generic drug?

Restasis Multidose is a brand-name product with the active ingredient Cyclosporine. Lower-cost generic equivalents containing Cyclosporine are available — ask your pharmacist.

Is Restasis Multidose available over the counter?

No. Restasis Multidose is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Restasis Multidose come in?

Restasis Multidose is currently marketed as emulsion, per the FDA's National Drug Code Directory.

What class of drug is Restasis Multidose?

Restasis Multidose is classified as calcineurin inhibitor immunosuppressant, per the FDA's Established Pharmacologic Class.

Is Restasis Multidose FDA-registered?

Restasis Multidose is on record with the U.S. FDA under application number NDA050790. You can verify this on its official FDA label.

Has Restasis Multidose been recalled by the FDA?

Restasis Multidose has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Restasis Multidose safe?

There's no single safe-or-not verdict. pharmaranks gives Restasis Multidose a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

What are the side effects of Restasis Multidose?

Restasis Multidose's side effects are taken directly from its FDA label. From the label: The following serious adverse reactions are described elsewhere in the labeling: Potential for Eye Injury and Contamination [ see Warnings and Precautions ( 5.1 ) ] The most common adverse reaction following the use of cyclosporine ophthalmic emulsion was ocular burning (17%).… Both common and serious reactions are documented in full on this page. This is general reference from the FDA, not medical advice — always consult a professional.